Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques

Molecular Therapy — Methods & Clinical Development(2021)10.1016/j.omtm.2021.06.008Source: DataRank Database

Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques is a research paper published in Molecular Therapy — Methods & Clinical Development (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 0.57)OA: goldTopics (28)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Yoshinori Fukazawa ORCID,Haesun Park ORCID,Benjamin Varco-Merth,Blake J. Rust ORCID,Jeremy Smedley ORCID

Live enrichment

PubMed:34485613 PMC:PMC8403686 OpenAlex:https://openalex.org/W3173151284

National Institutes of Health

Grant: UM1 A126623

National Institute of Allergy and Infectious Diseases

Grant: HHSN272201800007C

Oregon National Primate Research Center

Grant: P51OD011092

Oregon National Primate Research Center

Grant: ITS06.01

NIAID NIH HHS

Grant: UM1 AI126623

National Institutes of Health

Grant: 3P51OD011092-55S1

SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER

National Institutes of Health

Grant: 5UM1AI126623-02

Cell and Gene Therapy for HIV Cure

Bristol-Myers Squibb

Gilead Sciences Inc

Vaccine Research Center

Juno Therapeutics

Osaka University

St. Jude Children's Research Hospital

FWCI

0.57

Citation Percentile

0.7%

Citation Trend

2022

2024

2025

goldLicense: cc-by

journalhttp://www.cell.com/article/S2329050121001108/pdf

publisherhttp://www.cell.com/article/S2329050121001108/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2329050121001108?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2329050121001108?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.omtm.2021.06.008

Fields of Study

CAR-T cell therapy researchVirus-based gene therapy researchImmunotherapy and Immune Responses0301 basic medicine03 medical and health sciences

Keywords

VirologySimian immunodeficiency virusImmune systemAntigenBiologySimianImmunodeficiencyChimeric antigen receptorImmunologyVirusHuman immunodeficiency virus (HIV)ImmunotherapyInfectious diseasesHIVHumoral immune responseSIVAutologous Cell TherapyCar T cellsQH573-671QH426-470GeneticsOriginal ArticleCytology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being